Cite
Clinical application of catalytically cleavable fluorescence probe technology for multiplexing quantification of BCR–ABL1 fusion transcripts.
MLA
Park, Kyoung-Jin, et al. “Clinical Application of Catalytically Cleavable Fluorescence Probe Technology for Multiplexing Quantification of BCR–ABL1 Fusion Transcripts.” Clinica Chimica Acta, vol. 428, Jan. 2014, pp. 72–76. EBSCOhost, https://doi.org/10.1016/j.cca.2013.10.016.
APA
Park, K.-J., Woo, Y. M., Kim, K., Lee, S.-T., Ki, C.-S., Kim, H.-J., Kim, S.-H., & Kim, J.-W. (2014). Clinical application of catalytically cleavable fluorescence probe technology for multiplexing quantification of BCR–ABL1 fusion transcripts. Clinica Chimica Acta, 428, 72–76. https://doi.org/10.1016/j.cca.2013.10.016
Chicago
Park, Kyoung-Jin, Young Min Woo, Kwangwoo Kim, Seung-Tae Lee, Chang-Seok Ki, Hee-Jin Kim, Sun-Hee Kim, and Jong-Won Kim. 2014. “Clinical Application of Catalytically Cleavable Fluorescence Probe Technology for Multiplexing Quantification of BCR–ABL1 Fusion Transcripts.” Clinica Chimica Acta 428 (January): 72–76. doi:10.1016/j.cca.2013.10.016.